Constellium SE
CSTMConstellium SE's earnings have outrun its stock. EPS grew +405.3% in a year against a +124.5% price move.
The sharpest disagreement: annual EPS moved +405.3% against a +124.5% price move — the market has not yet caught up with the delivery.
The price is in a confirmed uptrend (38 weeks in). Underneath, the last four quarters read improving — profit +400.0% year on year, and 244% of the last 3 years' profit arrived as cash. What settles it: whether the price catches up with earnings that have already moved.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Constellium SE trades at $29.7, in a confirmed uptrend and 38 weeks into that stage. That is +17.6% against its own 200-day average. It sits at 72% of a 52-week range of $14 to $36. On relative strength it is currently behind the S&P 500 on a trailing-13-week view (6 weeks and counting).
Today the stock is in a confirmed uptrend — week 38 of stage 2. At $29.7 it trades +17.6% versus its 200-day average and sits at 72% of its 52-week range ($14–$36).
Against the market, two honest reads. Cumulative: over the last 10.1 years the stock moved +501% while the S&P 500 moved +263% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (6 weeks and counting; last ahead the week of 2026-06-26) — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation P/E is the price of $1 of annual profit: how many dollars the market pays for each dollar the company earns in a year.
Constellium SE trades at 7.7× P/E, against too little history to rank. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 7.7× is against too little history to rank. This is a comparison against the stock's own history — not a claim about what it is worth.
Why the multiple sits where it does: over the past year annual EPS moved +405.3% against a +124.5% price move — earnings outran the price, pushing the multiple DOWN its own range.
The price move, decomposed: over 3y, of the +17.7%/yr price move, ~+28.7%/yr came from earnings growth and ~−11.0 pp from the multiple (compressing). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is unremarkable against its own past, so the story rests on the earnings line underneath it, not the multiple.
Stage: Improving Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Constellium SE reads as improving on its fundamental arc. Improving — EPS growth bottomed 4 quarters ago at −58.1% and has held its recovery at +543.7%, ROCE holding at 9.5%. The read is built from 12 quarters across 4 curves, on full evidence.
Why it matters: a sustained climb off the trough is the setup this page is built to catch — the question moves to what you pay for it.
The latest quarter’s profit carries a one-off item larger than the operating base, so the profit curve is shown but does not vote in the stage call.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +15.3% | −1.0% | — | — |
| Profit | +366.7% | −5.3% | — | — |
| EPS | +405.3% | −2.9% | — | — |
| Stock price | +124.5% | +17.7% | +9.3% | +19.3% |
4-Factor Sector Score
61.7/100 — rank 1 of 4 in Aluminum · 55% evidence confidence
Constellium SE scores 61.7 out of 100 against the 4 companies it is compared with in Aluminum, ranking 1. Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
The four contributions add to the total exactly: 24.9 + 7.8 + 10 + 19 = 61.7. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
Constellium SE reported $2.5 B of revenue in the Mar 26 quarter, +24.2% year on year. That is the 5th straight quarter of year-on-year growth. Over 4 years it has compounded at 4.8% a year. The last full year, FY25, came in at $8.4 B. The last four reported quarters add to $8.9 B.
FY25 revenue came in at $8.4 B (+15.3% on the year), capping 4 years at 4.8% compound. The latest quarter (Mar 26) printed $2.5 B, +24.2% year on year — the 5th consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged +20.4% growth against the decade's 4.8% — the current year is running faster than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +20.2% over the last 4 quarters against +8.3%/yr over the last 8 — accelerating; TTM profit +340.0% vs +84.0%/yr — accelerating.
Operating margin Operating margin is what is left of every $100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
Constellium SE's operating margin is 12.2% in the Mar 26 quarter, +7.7 percentage points against the same quarter a year ago. Across 5 fiscal years the operating margin has ranged 3.4% to 7.9%. The current quarter is running above every full year in that window.
The latest quarter's operating margin is 12.2%, +7.7 pp against the same quarter a year ago. Across 5 fiscal years the operating margin has ranged 3.4%–7.9%.
Why the margin moved: operating margin went +7.7 pp year on year while gross margin went +4.0 pp — the gain came mostly below the gross line: operating leverage, with costs spread over a bigger revenue base.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Constellium SE earned $0.2 B of net profit in the Mar 26 quarter, +400.0% year on year. Full-year FY25 profit was $0.3 B. The 4-year compound rate is −1.7%. That is 8.1% of the quarter's revenue. The same quarter a year earlier earned $0.0 B. 1 of the last 12 reported quarters were loss-making.
Mar 26 profit was $0.2 B, +400.0% year on year. On the full year, FY25 printed $0.3 B (+366.7%), and the 4-year compound rate is −1.7%.
Why profit moved: revenue contributed +24.2% and the margin +7.7 pp — the quarter was margin-led: most of the profit growth came from keeping more of each sale.
Pace comparison, last four quarters: profit +383.3% vs revenue +20.4%. Profit is growing faster than sales — fixed costs are being spread over a bigger base, and each extra dollar of revenue drops more to the bottom line.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years 244% of Constellium SE's reported profit arrived as operating cash — the cash follows the profit. In FY25 that was $0.5 B of operating cash against $0.3 B of profit. After $0.3 B of capital spending, $0.2 B was left as free cash.
FY25: operating cash of $0.5 B against reported profit of $0.3 B, leaving free cash of $0.2 B after $0.3 B of capital spending. Across the last 3 fiscal years the conversion rate is 244% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
Why: conversion is measured cleanly, but the working-capital day-counts behind it sit below what we hold — the move is shown without inventing its driver.
Router verdict: the visible cash user is investment — the next section checks what the spending is buying.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
Constellium SE does not report the debtor, inventory and payable day-counts a cash cycle is built from, so this section reads the investment side instead. Capital spending ran $1.0 B over the last 3 years. Averaged over those years that is 3.9% of FY25 revenue a year.
Working-capital day-counts are not in our numbers for this stock, so this section reads the investment side — where the cash is being put to work.
On the investment side: capital spending of $1.0 B over the last 3 fiscal years.
The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.
Return on equity Return on equity (ROE) is the profit the business earns on its shareholders’ money. With the full capital-employed split not in our numbers, ROE is the cleanest long ladder we can draw here.
Constellium SE earns a ROE of 37% in FY25. That is up from a trough of 9% in FY24. Return on invested capital clears the cost of that capital by +11.6 percentage points, so growth here adds value rather than only size. The wiring behind it is 3.3% net margin on 1.58× asset turns.
FY25 ROE is 37%, recovered from a FY24 trough of 9% — the full ladder below shows the fall and the climb, undoctored.
Why the return is what it is — the wiring (FY25): 3.3% net margin × 1.58× asset turns × 7.13× balance-sheet leverage ≈ 37.2% on equity. Margin does its share; leverage is a meaningful part of the equation.
The capstone test — ROIC − WACC: 21.4% − 9.8% = a +11.6 pp spread. The 9.8% is an estimate of this company's own cost of capital — read the sign and the size of the spread, not the decimals. A spread this wide means every dollar reinvested creates more than a dollar of value — the engine compounds.
Dividend
Constellium SE pays no dividend. Across the last 12 reported quarters it has declared no dividend per share, so there is no payout history to chart and no yield to quote. Companies at this stage typically reinvest earnings rather than distribute them, which makes the cash-flow and reinvestment sections the place that cash shows up.
Constellium SE does not currently pay a dividend. Across the last 12 reported quarters the company has declared no dividend per share, so there is no payout history to chart and no yield to quote. Companies at this stage typically reinvest earnings instead of distributing them.
Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.
Constellium SE carries total debt of $1.9 B against shareholder equity of $1.3 B as of Jun 26, a debt-to-equity of 1.54. On the annual view that ratio went from 7.33 in FY21 to 2.59 in FY25. Read the returns elsewhere on this page with that leverage in mind.
Jun 26: total debt of $1.9 B against shareholder equity of $1.3 B — a debt-to-equity of 1.54. On the annual view, debt-to-equity went from 7.33 (FY21) to 2.59 (FY25). Read the returns on this page with that leverage in mind.
Ownership There is no quarter-by-quarter holder register to read here, so we read the crowd through short interest — the slice of tradable shares currently sold short, positioned for a fall.
No ownership or positioning reading is held for Constellium SE, so this section names the gap rather than filling it. At typical trading volumes those positions would take about 3.5 days to buy back. There is no quarter-by-quarter holder register to read for this filer, so the crowd is read through short interest instead.
We hold no ownership or positioning reading for this stock, so this section says that plainly.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Constellium SE: the Z-score reads 2.79. A Z-score above roughly 3 reads as safe and below roughly 1.8 as the distress zone, so this sits in the grey band between the two. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure.
Why it matters: a Z-score of 2.79 sits in the grey band — neither clearly safe nor clearly distressed.
The safety line in one sentence: the Z-score reads 2.79.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Constellium SEthis pageCSTM | 61.7/100Thin evidence · provisional55% evidence | ASLEEP | 24.9/35 Revenue — · PAT — · OPM change 7.7 pp 45% evidence | 7.8/25 ROCE 6.7% · OPM 12.2% 76% evidence | 10.0/20 P/E 8.2× · PEG — 0% evidence | 19.0/20 RS sector 8.8% · RS bench 15.5% · 1Y 120.2%6 of 12 weeks ahead 100% evidence |
| Exact sum: 24.9 + 7.8 + 10 + 19 = 61.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 2Kaiser Aluminum CorporationKALU | 61.1/100Thin evidence · provisional55% evidence | ASLEEP | 24.6/35 Revenue — · PAT — · OPM change 3.5 pp 45% evidence | 6.5/25 ROCE 6.1% · OPM 8.8% 76% evidence | 10.0/20 P/E 14.5× · PEG — 0% evidence | 20.0/20 RS sector 17.2% · RS bench 24.8% · 1Y 136.2%7 of 12 weeks ahead 100% evidence |
| Exact sum: 24.6 + 6.5 + 10 + 20 = 61.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 3Century Aluminum CompanyCENX | 56.8/100Mixed-positive evidence68% evidence | ASLEEP | 26.8/35 Revenue 7.5% · PAT 100% · OPM change 50.8 pp 83% evidence | 18.6/25 ROCE 20.7% · OPM 57.6% 76% evidence | 10.0/20 P/E 17.5× · PEG — 0% evidence | 1.4/20 RS sector -7.1% · RS bench -2.2% · 1Y 104.8%2 of 12 weeks ahead 100% evidence |
| Exact sum: 26.8 + 18.6 + 10 + 1.4 = 56.8 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -7.1% and the one-year return is 104.8%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 4Alcoa CorporationAA | 37.0/100Thin evidence · provisional55% evidence | ASLEEP | 19.0/35 Revenue — · PAT — · OPM change -7.8 pp 45% evidence | 8.0/25 ROCE 5.8% · OPM 12.8% 76% evidence | 10.0/20 P/E 10.8× · PEG — 0% evidence | 0.0/20 RS sector -23.3% · RS bench -18% · 1Y 55.2%3 of 12 weeks ahead 100% evidence |
| Exact sum: 19 + 8 + 10 + 0 = 37 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led S&P 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is Constellium SE's stock price today?
Constellium SE trades at $29.7, +124.5% over the past year. The company is valued at $4.0 B. The stock sits at 72% of its 52-week range of $14–$36, +17.6% versus its 200-day average. On the tape, the price is in a confirmed uptrend, 38 weeks in. — as of 5 August 2026.
What were Constellium SE's latest quarterly results?
Constellium SE reported revenue of $2.5 B and net profit of $0.2 B for the Mar 26 quarter. Revenue rose 24.2% and profit rose 400.0% year on year. Earnings per share were $1.42. The operating margin was 12.2%, 7.7 pp higher than a year earlier. — as of 5 August 2026.
What is Constellium SE's revenue?
Constellium SE reported revenue of $2.5 B in the Mar 26 quarter, +24.2% year on year. For the full FY25 fiscal year, revenue was $8.4 B (+15.3%). Over the last 4 years revenue compounded at 4.8% a year. — as of 5 August 2026.
What is Constellium SE's profit?
Constellium SE earned $0.2 B of net profit in the Mar 26 quarter, +400.0% year on year. Full-year FY25 profit was $0.3 B. The operating margin ran 12.2% in the latest quarter. — as of 5 August 2026.
What is Constellium SE's market cap?
Constellium SE's market capitalisation is $4.0 B at a stock price of $29.7. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 5 August 2026.
Does Constellium SE pay a dividend?
No — Constellium SE has declared no dividend per share in any of its last 12 reported quarters, so there is no payout history and no yield to quote. That is a reading of the filed statements, not an estimate. — as of 5 August 2026.
Is Constellium SE growing?
Yes — Constellium SE is growing: latest-quarter revenue +24.2% year on year, profit +400.0%, and the margin +7.7 pp at 12.2%. The 4-year compound rates are 4.8% (revenue) and −1.7% (profit). The earnings engine currently reads: improving — as of 5 August 2026.
How is Constellium SE performing?
Constellium SE is in a confirmed uptrend, 38 weeks in. Its latest quarter's revenue rose 24.2% and profit rose 400.0% year on year. Against the S&P 500 it has been behind on a trailing-13-week view for 6 weeks. This describes what the data did, not a rating. — as of 5 August 2026.
What stage is Constellium SE in?
Improving — EPS growth bottomed 4 quarters ago at −58.1% and has held its recovery at +543.7%, ROCE holding at 9.5%. The read comes from the last 12 quarters of growth (revenue growth +20.2% latest, profit growth +340.0% latest, eps growth +543.7% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 5 August 2026.
Is Constellium SE in an uptrend?
Yes — the price is in a confirmed uptrend (week 38 of stage 2), trading +17.6% versus its 200-day average and at 72% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 5 August 2026.
Is Constellium SE beating the market?
Not lately — on a trailing-13-week view Constellium SE is currently behind the S&P 500 (6 weeks and counting; last ahead the week of 2026-06-26), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.1 years the stock moved +501% against the S&P 500's +263% — ahead of the index over the full window. — as of 5 August 2026.
Will Constellium SE's stock price go up?
This page publishes no price forecast for Constellium SE. What it measures instead: the stock price is $29.7, the price is in a confirmed uptrend 38 weeks in. Direction is not something this site claims to know. — as of 5 August 2026.
Does Constellium SE have too much debt?
It carries real leverage — Constellium SE's debt-to-equity is 1.53. A year-by-year borrowings ladder is not in our numbers for this stock, so the latest reading is the cleanest hold. Read the returns on this page with that leverage in mind — as of 5 August 2026.
What is Constellium SE's capex?
Constellium SE spent $1.0 B on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY25 alone that was $0.3 B. — as of 5 August 2026.
What is Constellium SE's cash flow?
Constellium SE generated $0.5 B of operating cash flow in FY25 and $0.2 B of free cash flow after $0.3 B of capital spending. Reported profit that year was $0.3 B, so operating cash ran ahead of profit. — as of 5 August 2026.
Is Constellium SE's profit real cash?
Yes — over the last 3 fiscal years, 244% of Constellium SE's reported profit arrived as operating cash. In FY25, operating cash was $0.5 B against reported profit of $0.3 B. The cash then goes mostly into building capacity. Cash-flow resolution is annual — as of 5 August 2026.
How financially safe is Constellium SE?
On the balance sheet, the Z-score reads 2.79 — above roughly 3 is safe, below roughly 1.8 is the distress zone. That is in the grey band — neither clearly safe nor clearly distressed. — as of 5 August 2026.
Where is Constellium SE in its business cycle?
Constellium SE's FY25 operating margin was 6.2%, against a 5-year band of 3.4%–7.9%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran 12.2%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 5 August 2026.
What could break the Constellium SE story?
The sharpest disagreement: annual EPS moved +405.3% against a +124.5% price move — the market has not yet caught up with the delivery. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 5 August 2026.
Is Constellium SE a stock worth studying right now?
This is not investment advice. The machine read: Constellium SE's earnings have outrun its stock. EPS grew +405.3% in a year against a +124.5% price move. The sharpest open question: whether the price catches up with earnings that have already moved. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 5 August 2026.